Deficiency of Siglec-G results in an even greater increase of IgM antibodies despite excessive hypercholesterolemia, and thus Siglec-G may be an attractive target for therapeutic intervention, for example, by blocking antibodies. The gene discussed is CD40LG; the disease is familial hypercholesterolemia.